Conference Reporter

Oncology

Conference Reporter® in GEP-NETS to Cover Key Topics Being Presented at the 2026 SNMMI Annual Meeting

Oncology

Conference Reporter® in HR+/HER2- Early Breast Cancer to Cover Key Topics Being Presented at ASCO 2026

Dermatology

The Selection of Systemic Therapies for Plaque Psoriasis: Challenging Cases

conference reporter
By Eingun James Song, MD, FAAD

Oncology

Novel Drug Candidates, Targets, and Combinations for Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Diane Reidy-Lagunes, MD

Dermatology

Update on Systemic Therapies for Plaque Psoriasis

conference reporter
By Eingun James Song, MD, FAAD

Oncology

Gastroenteropancreatic Neuroendocrine Tumors: Patient Engagement, Partnerships, and Technology-Enabled Care

conference reporter
By Diane Reidy-Lagunes, MD

Oncology

Liquid Biopsy for Defining Risk and Tailoring Treatment in HR+/HER2- Metastatic Breast Cancer

conference reporter
By Angela M. DeMichele, MD, MSCE, FASCO

Oncology

Recognizing and Managing Treatment-Related Toxicities in Metastatic Breast Cancer

conference reporter
By Angela M. DeMichele, MD, MSCE, FASCO

Oncology

Treatment Resistance in HR+/HER2- Metastatic Breast Cancer

conference reporter
By Sonya Reid, MD, MPH

Oncology

Disparities in Care for HR+/HER2- Breast Cancer

conference reporter
By Sonya Reid, MD, MPH

Oncology

The Treatment of HR+/HER2- Stage III Breast Cancer

conference reporter
By Seth A. Wander, MD, PhD

Oncology

Personalized Treatment for Primary Central Nervous System Lymphoma

conference reporter
By Christopher R. D’Angelo, MD

Oncology

Novel Therapies and Drugs in Development for Primary Central Nervous System Lymphoma

conference reporter
By Christopher R. D’Angelo, MD

Oncology

Measurable Residual Disease: Earlier Relapse Detection in Early-Stage Breast Cancer

conference reporter
By Seth A. Wander, MD, PhD

Oncology

Adjuvant CDK4/6 Inhibitor Therapy for HR+/HER2- Early-Stage Breast Cancer

conference reporter
By Erica L. Mayer, MD, MPH

Rheumatology

Systemic Lupus Erythematosus Risk and Prevention

conference reporter
By Jennifer L. Rogers, MD

Nephrology

Renoprotective Strategies in IgA Nephropathy: Conference-to-Clinic Highlights

conference reporter
By Pietro A. Canetta, MD, MS

Oncology

Primary Central Nervous System Lymphoma Treatment Goals and Outcomes

conference reporter
By Matthias Holdhoff, MD, PhD

Rheumatology

Quality of Life in Systemic Lupus Erythematosus

conference reporter
By Jennifer L. Rogers, MD

Oncology

SABCS 2025 Highlights on HR+/HER2- Early-Stage Breast Cancer

conference reporter
By Erica L. Mayer, MD, MPH

Dermatology

6th Annual Elevate-Derm Fall Conference Highlights

conference reporter
By Douglas DiRuggiero, DMSc, MHS, PA-C

Nephrology

The Pathogenesis of IgA Nephropathy and Insights Into B-Cell Modulation

conference reporter
By Pietro A. Canetta, MD, MS

Dermatology

Conference Reporter® in Plaque Psoriasis to Cover Key Topics Being Presented at Maui Derm 2026

conference reporter
By Jason Ezra Hawkes, MD, MS, FAAD; Eingun James Song, MD, FAAD

Dermatology

A Physician Assistant’s Perspective on Navigating Today’s Treatments for Moderate to Severe Plaque Psoriasis

conference reporter
By Douglas DiRuggiero, DMSc, MHS, PA-C

Rheumatology

B-Cell–Directed Therapies for Systemic Lupus Erythematosus

conference reporter
By Anca D. Askanase, MD, MPH

Oncology

The Potential Role of BTK Inhibitors in Treating Newly Diagnosed Primary Central Nervous System Lymphoma

conference reporter
By Matthias Holdhoff, MD, PhD

Oncology

Expert Roundtables Podcast: Myelofibrosis – Frontiers and Future Directions

conference reporter
By Gabriela S. Hobbs, MD; Andrew Kuykendall, MD; Lucia Masarova, MD

Dermatology

The Role of Oral Therapies in the Injectable Treatment Landscape for Plaque Psoriasis

conference reporter
By Eingun James Song, MD, FAAD

Cardiology

Evolving Treatment Strategies for Low-Density Lipoprotein Cholesterol Reduction

conference reporter
By Payal Kohli, MD, FACC

Dermatology

SDPA 23rd Annual Fall Dermatology Conference Highlights

conference reporter
By Diego Ruiz Dasilva, MD, FAAD

Dermatology

The Long-term Use of IL-23 Inhibitors for Plaque Psoriasis: Emerging Evidence

conference reporter
By Eingun James Song, MD, FAAD

Rheumatology

Autonomic Neuropathy in Sjögren’s Disease

conference reporter
By R. Hal Scofield, MD

Cardiology

The Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach

conference reporter
By Seth Martin, MD, MHS

Cardiology

Conference Reporter® in Lp(a) to Cover Key Topics Being Presented at the 2026 ACC Conference

conference reporter

Allergy & Immunology

Conference Reporter® in Chronic Spontaneous Urticaria to Cover Key Topics Being Presented at the AAAAI 2026

conference reporter
By Jonathan A. Bernstein, MD; David M. Lang, MD

Allergy & Immunology

Conference Reporter® in Food Allergies to Cover Key Topics Being Presented at the AAAAI 2026

conference reporter

Nephrology

IgA Nephropathy: Translating Guidelines Into Clinical Practice

conference reporter
By Myda Khalid, MD

Oncology

Special Considerations in Treating Older Adults With Metastatic Breast Cancer

conference reporter
By Sara M. Tolaney, MD, MPH

Oncology

Updates on HR+/HER2- Metastatic Breast Cancer: Highlights From ESMO

conference reporter
By Sara M. Tolaney, MD, MPH

Oncology

Conference Reporter® in GEP-NETs to Cover Key Topics Being Presented at the 2026 ASCO Gastrointestinal Cancers Symposium

conference reporter
By Thorvadur R. Halfdanarson, MD; Diane Reidy-Lagunes, MD

Rheumatology

Management Recommendations and Guidelines for Sjögren’s Disease

conference reporter
By R. Hal Scofield, MD

Oncology

Recent Data on CDK4/6 Inhibitors for HR+/HER2- Metastatic Breast Cancer

conference reporter
By William J. Gradishar, MD, FACP

Oncology

Conference Reporter® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics Being Presented at SABCS 2025

conference reporter
By Angela M. DeMichele, MD, MSCE, FASCO; Sonya Reid, MD, MPH

Cardiology

The Role of Genetics in Familial Hypercholesterolemia

conference reporter
By Seth Martin, MD, MHS

Oncology

Later-line Treatment for HR+/HER2- Metastatic Breast Cancer

conference reporter
By William J. Gradishar, MD, FACP

Dermatology

New and Emerging TYK2 Inhibitors for Plaque Psoriasis

conference reporter
By Raj Chovatiya, MD, PhD, MSCI

Rheumatology

Sjögren’s Disease Pathogenesis and Treatment Targets

conference reporter
By Nancy Carteron, MD, FACR

Rheumatology

Systemic Lupus Erythematosus Treatment Guideline Updates and Highlights

conference reporter
By Anca D. Askanase, MD, MPH

Nephrology

Emerging Therapies and Clinical Trials in IgA Nephropathy

conference reporter
By Myda Khalid, MD

Dermatology

Diagnostic Perspectives on Plaque Psoriasis

conference reporter
By Diego Ruiz Dasilva, MD, FAAD

Oncology

Personalizing Hormone Therapy in Recurrent Prostate Cancer

conference reporter
By Daniel E. Spratt, MD

Oncology

Conference Reporter® in Myelofibrosis 2025 American Society of Hematology Annual Meeting

conference reporter
By Andrew Kuykendall, MD; Gabriela S. Hobbs, MD; Lucia Masarova, MD

Dermatology

Updates on the Topical Therapy Landscape in Plaque Psoriasis

conference reporter
By Raj Chovatiya, MD, PhD, MSCI

Oncology

Conference Reporter® in HR+/HER2- Early Breast Cancer to Cover Key Topics Being Presented at SABCS 2025

conference reporter
By Erica L. Mayer, MD, MPH; Seth A. Wander, MD, PhD

Rheumatology

Oral and Ocular Manifestations of Sjögren’s Disease

conference reporter
By Nancy Carteron, MD, FACR

Oncology

Artificial Intelligence-Digital Pathology and Its Potential Across the Disease Continuum

conference reporter
By Daniel E. Spratt, MD

Oncology

Conference Reporter® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics Being Presented at ESMO 2025

conference reporter
By William J. Gradishar, MD, FACP; Sara M. Tolaney, MD, MPH

Oncology

Metastasis-Directed Therapy: Multimodal Strategies and Future Directions

conference reporter
By Amar U. Kishan, MD

Oncology

Radiation and the Biology of Oligometastatic Prostate Cancer

conference reporter
By Amar U. Kishan, MD

Oncology

Conference Reporter® in Primary Central Nervous System Lymphoma to Cover Key Topics Being Presented at the 2025 American Society of Hematology Annual Meeting

conference reporter
By Christopher R. D’Angelo, MD; Matthias Holdhoff, MD, PhD

Cardiology

Conference Reporter® in Hypercholesterolemia to Cover Key Topics Being Presented at the AHA Scientific Sessions 2025

conference reporter
By Payal Kohli, MD, FACC; Seth Martin, MD, MHS

Dermatology

Conference Reporter® in Plaque Psoriasis to Cover Key Topics Being Presented at the Society of Dermatology Physician Associates & Elevate-Derm Fall Conferences 2025

conference reporter
By Diego Ruiz Dasilva, MD, FAAD; Douglas DiRuggiero, DMSc, MHS, PA-C

Rheumatology

Conference Reporter® in Sjögren’s Disease to Cover Key Topics Being Presented at ACR Convergence 2025

conference reporter
By Nancy Carteron, MD, FACR; R. Hal Scofield, MD

Dermatology

Conference Reporter® in Plaque Psoriasis to Cover Key Topics Being Presented at the 2025 Fall Clinical Dermatology Conference

conference reporter
By Raj Chovatiya, MD, PhD, MSCI; Eingun James Song, MD, FAAD

Nephrology

Conference Reporter® in IgAN to Cover Key Topics Being Presented at ASN 2025

conference reporter
By Duvuru Geetha, MBBS; Joshua M. Thurman, MD

Rheumatology

Conference Reporter® in Systemic Lupus Erythematosus to Cover Key Topics Being Presented at ACR Convergence 2025

conference reporter
By Anca D. Askanase, MD, MPH; Jennifer L. Rogers, MD

Oncology

Imaging-Based Predictive Models for Peptide Receptor Radionuclide Therapy

conference reporter
By Jonathan R. Strosberg, MD

Oncology

Conference Reporter® in Metastatic Prostate Cancer to Cover Key Topics Being Presented at ASTRO 2025

conference reporter
By Amar U. Kishan, MD; Daniel E. Spratt, MD

Neurology

Understanding the Cognitive Impact of Spinal Muscular Atrophy

conference reporter
By Julie A. Parsons, MD

Oncology

Peptide Receptor Radionuclide Therapy and Treatment Sequencing for Gastroenteropancreatic Neuroendocrine Tumors

By Jonathan R. Strosberg, MD

Oncology

Prostate-Specific Membrane Antigen–Targeted Therapy: Novel Strategies and Alternative Radionuclides

conference reporter
By Delphine L. Chen, MD

Oncology

Advanced Prostate Cancer Theranostics: Trials in Progress With Actinium

conference reporter
By Delphine L. Chen, MD

Neurology

Assessing Outcomes in Spinal Muscular Atrophy to Optimize Clinical Care

conference reporter
By Julie A. Parsons, MD

Oncology

Clarifying the Association Between Obesity and Endometrial Cancer

conference reporter
By John K. Chan, MD

Oncology

Treatment Considerations in Older Adults With Early-Stage HR+/HER2- Breast Cancer

conference reporter
By Harold J. Burstein, MD, PhD

Oncology

Somatostatin Receptor Expression Profiles in the Treatment of Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Daniel M. Halperin, MD

Neurology

Orthopedic Considerations for Patients Living With Spinal Muscular Atrophy

conference reporter
By Brian D. Snyder, MD, PhD

Oncology

Integrating Theranostics: New Opportunities in Advanced Prostate Cancer

conference reporter
By Oliver Sartor, MD

Oncology

Treatment Options for Advanced and Recurrent Endometrial Cancer

conference reporter
By John K. Chan, MD

Oncology

Prostate Cancer Theranostics: A Snapshot of the Clinical Research Ecosystem

conference reporter
By Oliver Sartor, MD

Oncology

Adjuvant Systemic Therapy for Early-Stage HR+/HER2- Breast Cancer

conference reporter
By Harold J. Burstein, MD, PhD

Rheumatology

Cutaneous Manifestations in Systemic Lupus Erythematosus

conference reporter
By Lisa G. Criscione-Schreiber, MD, MEd

Oncology

The Initial Management of Advanced Ovarian Cancer

conference reporter
By Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS

Neurology

Long-term Motor Functioning in Spinal Muscular Atrophy

conference reporter
By Brian D. Snyder, MD, PhD

Oncology

Biomarker-Driven Optimization in Metastatic Prostate Cancer

conference reporter
By Neeraj Agarwal, MD, FASCO

Oncology

Advancements in Targeted Therapies for Metastatic Prostate Cancer: Investigational Combinations and New Targets

conference reporter
By Neeraj Agarwal, MD, FASCO

Oncology

Prostate Cancer Theranostics: A Snapshot of the Clinical Research Ecosystem

By Oliver Sartor, MD

Oncology

Dosimetry-Guided Peptide Receptor Radionuclide Therapy and Perspectives on the Future

conference reporter
By Daniel M. Halperin, MD

Oncology

Treatment Options for Platinum-Resistant Ovarian Cancer

conference reporter
By Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS

Oncology

Radiopharmaceutical Therapy in Advanced Prostate Cancer

conference reporter
By Jeremie Calais, MD, PhD

Rheumatology

Health Disparities in Systemic Lupus Erythematosus

conference reporter
By Lisa G. Criscione-Schreiber, MD, MEd

Oncology

CDK4/6 Inhibitor Therapy for High-Risk Early-Stage HR+/HER2- Breast Cancer

conference reporter
By Melinda L. Telli, MD, FASCO

Oncology

Recent Analyses From Clinical Trials in Advanced Endometrial Cancer

conference reporter
By Ramez N. Eskander, MD

Rheumatology

Organ Damage in Systemic Lupus Erythematosus

conference reporter
By Michelle Petri, MD, MPH

Oncology

Personalized Treatment for Ovarian Cancer

conference reporter
By Kathleen N. Moore, MD, MS, FASCO

Oncology

Prostate-Specific Membrane Antigen–Targeted Radioligand Therapies for Prostate Cancer

conference reporter
By Jeremie Calais, MD, PhD

Oncology

New Treatment Options and Targets for Endometrial Cancer

conference reporter
By Ramez N. Eskander, MD

Oncology

Gene Expression Profiling for Early-Stage HR+/HER2- Breast Cancer

conference reporter
By Melinda L. Telli, MD, FASCO

Dermatology

Key Takeaways From the 2025 American Academy of Dermatology Annual Meeting

conference reporter
By Peter A. Lio, MD

Nephrology

Diagnosing and Treating Dense Deposit Disease and C3 Glomerulonephritis

conference reporter
By Richard Lafayette, MD, FACP

Rheumatology

Targeted Therapies for Systemic Lupus Erythematosus

conference reporter
By Michelle Petri, MD, MPH

Oncology

Molecularly Guided Treatment of Advanced Endometrial Cancer

conference reporter
By Bradley J. Monk, MD, FACS, FACOG

Nephrology

Novel Agents Targeting the Complement System in C3 Glomerulopathy

conference reporter
By Richard Lafayette, MD, FACP

Dermatology

Dietary and Supplementation Strategies for Atopic Dermatitis

conference reporter
By Peter A. Lio, MD

Neurology

Conference Reporter® in Spinal Muscular Atrophy to Cover Key Topics Being Presented at CureSMA 2025

conference reporter
By Julie A. Parsons, MD; Brian D. Snyder, MD, PhD

Oncology

Conference Reporter® in Metastatic Prostate Cancer to Cover Key Topics Being Presented at the 2025 SNMMI Annual Meeting

conference reporter
By Delphine L. Chen, MD; Oliver Sartor, MD

Oncology

Conference Reporter® in GEP-NETS to Cover Key Topics Being Presented at the 2025 SNMMI Annual Meeting

conference reporter
By Daniel M. Halperin, MD; Jonathan R. Strosberg, MD

Oncology

Endometrial Cancer Biomarkers

conference reporter
By Bradley J. Monk, MD, FACS, FACOG

Nephrology

Future Directions and Long-term Outcomes in C3 Glomerulopathy

conference reporter
By Purva Sharma, MD

Cardiology

Present and Future Management of Dyslipidemia

conference reporter
By Steven E. Nissen, MD, MACC

Cardiology

Novel Therapeutic Agents for Managing Elevated Lipoprotein(a) Levels

conference reporter
By Steven E. Nissen, MD, MACC

Nephrology

Conference Reporter® in Renoprotective Strategies in IgAN to Cover Key Topics Being Presented at ASN Kidney Week 2025

conference reporter
By Pietro A. Canetta, MD, MS; Myda Khalid, MD

Cardiology

Available and Emerging PCSK9-Targeted Treatments to Lower Low-Density Lipoprotein Cholesterol and Lipoprotein(a)

conference reporter
By Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI

Nephrology

Evaluating and Diagnosing Patients With Suspected C3 Glomerulopathy

conference reporter
By Purva Sharma, MD

Oncology

Delays and Disparities in the Diagnosis and Treatment of Endometrial Cancer

conference reporter
By Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS

Oncology

Conference Reporter® in Ovarian Cancer to Cover Key Topics Being Presented at ASCO 2025

conference reporter
By Kathleen N. Moore, MD, MS, FASCO ; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS

Oncology

Conference Reporter® in Endometrial Cancer to Cover Key Topics Being Presented at ASCO 2025

conference reporter
By John K. Chan, MD; Ramez N. Eskander, MD

Oncology

Conference Reporter® in Metastatic Prostate Cancer to Cover Key Topics Being Presented at ASCO 2025

conference reporter
By Neeraj Agarwal, MD, FASCO; Jeremie Calais, MD, PhD

Oncology

Conference Reporter® in HR+/HER2- Early Breast Cancer to Cover Key Topics Being Presented at ASCO 2025

conference reporter
By Harold J. Burstein, MD, PhD; Melinda L. Telli, MD, FASCO

Cardiology

Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease

conference reporter
By Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI

Oncology

Endometrial Cancer Staging

conference reporter
By Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS

Dermatology

Atopic Dermatitis in Adults vs Children

conference reporter
By Jonathan I. Silverberg, MD, PhD, MPH

Dermatology

Immunological Pathways Targeted in the Treatment of Atopic Dermatitis With Biologics

conference reporter
By Jonathan I. Silverberg, MD, PhD, MPH

Rheumatology

Conference Reporter in Systemic Lupus Erythematosus to Cover Key Topics Being Presented at CCR East 2025

conference reporter
By Michelle Petri, MD, MPH; Lisa G. Criscione-Schreiber, MD, MEd

Oncology

Disparities in Neuroendocrine Tumor Outcomes

conference reporter
By Jennifer R. Eads, MD

Nephrology

Conference Reporter in C3 Glomerulopathy to Cover Key Topics Being Presented at the National Kidney Foundation Spring Clinical Meeting 25

conference reporter
By Richard Lafayette, MD, FACP; Purva Sharma, MD

Hematology

Paroxysmal Nocturnal Hemoglobinuria: Future Directions and Clinical Trials

conference reporter
By Ronald S. Go, MD

Hematology

Health-Related Quality of Life and Real-World Data on Paroxysmal Nocturnal Hemoglobinuria Treatment

conference reporter
By Ronald S. Go, MD

Hematology

Thrombotic Risk in Paroxysmal Nocturnal Hemoglobinuria: Genetic Sources of Variability?

conference reporter
By Vahid Afshar-Kharghan, MD

Dermatology

Treating Psoriasis in Patients With Skin of Color

conference reporter
By Jason Ezra Hawkes, MD, MS, FAAD

Oncology

Theranostics in Gastrointestinal Cancers

conference reporter
By Jennifer R. Eads, MD

Oncology

Integrative and Complementary Approaches for Patients With Gastrointestinal Cancers

conference reporter
By Diane Reidy-Lagunes, MD

Cardiology

Conference Reporter® in Lp(a) to Cover Key Topics Being Presented at the ACC 25

conference reporter
By Steven E. Nissen, MD, MACC; Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI

Dermatology

Pipeline Therapies for Psoriasis

conference reporter
By Jason Ezra Hawkes, MD, MS, FAAD

Dermatology

Conference Reporter® in Atopic Dermatitis to Cover Key Topics Being Presented at the 2025 AAD Annual Meeting

conference reporter
By Peter A. Lio, MD; Jonathan I. Silverberg, MD, PhD, MPH

Oncology

Conference Reporter® in Endometrial Cancer to Cover Key Topics Being Presented at the 2025 SGO Annual Meeting on Women’s Cancer

conference reporter
By Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Bradley J. Monk, MD, FACS, FACOG

Dermatology

Goals and Benefits of Topical Therapy for Psoriasis

conference reporter
By Linda Stein Gold, MD

Oncology

Rare Gastrointestinal Cancers: Colorectal Neuroendocrine Tumors in Focus

conference reporter
By Diane Reidy-Lagunes, MD

Dermatology

Oral vs Biologic Therapy for the Treatment of Mild to Moderate Psoriasis

conference reporter
By Linda Stein Gold, MD

Oncology

Updates on Alpha-Particle–Emitting Somatostatin Analogues

conference reporter
By Jennifer R. Eads, MD

Hematology

Complement Inhibitor Monitoring in Paroxysmal Nocturnal Hemoglobinuria: Tips and Tools for Clinicians and Researchers

conference reporter
By Vahid Afshar-Kharghan, MD

Oncology

Gastroenteropancreatic Neuroendocrine Neoplasms: New Frontiers and Novel Treatment Strategies

conference reporter
By Jennifer R. Eads, MD

Dermatology

Special Patient Populations With Psoriasis

conference reporter
By Douglas DiRuggiero, DMSc, MHS, PA-C

Rheumatology

Flares and Disease Activity in Systemic Lupus Erythematosus

conference reporter
By George C. Tsokos, MD

Dermatology

Society of Dermatology Physician Associates 22nd Annual Fall Dermatology Conference Roundup

conference reporter
By Douglas DiRuggiero, DMSc, MHS, PA-C

Oncology

Genotype-Phenotype Correlations in Neuroendocrine Tumors

conference reporter
By Diane Reidy-Lagunes, MD

Dermatology

What Clinicians Need to Know About Comorbidities Associated With Psoriasis

conference reporter
By Joel M. Gelfand, MD, MSCE

Oncology

Conference Reporter® in GEP-NETs to Cover Key Topics Being Presented at the 2025 ASCO Gastrointestinal Cancers Symposium

conference reporter
By Jennifer R. Eads, MD; Diane Reidy-Lagunes, MD

Dermatology

Plaque Psoriasis and the Evolution of Biologics

conference reporter
By Steven R. Feldman, MD, PhD

Rheumatology

Glucocorticoids and Reducing Glucocorticoid Use in Systemic Lupus Erythematosus

conference reporter
By Anca D. Askanase, MD, MPH

Oncology

Screening, Testing, and Clinical Trial Participation Among African American Men

conference reporter
By William K. Oh, MD

Oncology

Prostate Cancer Disparities, Genomics, and African Ancestry

conference reporter
By Neha Vapiwala, MD, FACR, FASTRO, FASCO

Nephrology

IgA Nephropathy: Novel and Investigational Targeted Therapies

conference reporter
By Sayna Norouzi, MD, FASN

Dermatology

Conference Reporter® in Plaque Psoriasis to Cover Key Topics Being Presented at Maui Derm Hawaii 2025

conference reporter

Oncology

Immunotherapeutic Strategies for Advanced Prostate Cancer

conference reporter
By Matthew R. Smith, MD, PhD

Allergy & Immunology

Aging and Food Allergies

conference reporter
By Sayantani Sindher, MD

Allergy & Immunology

Emerging Treatments for Chronic Spontaneous Urticaria

conference reporter
By Jonathan A. Bernstein, MD

Oncology

Prostate-Specific Membrane Antigen Positron Emission Tomography: Next-Generation Imaging in Prostate Cancer

conference reporter
By Matthew R. Smith, MD, PhD

Dermatology

New Treatment Options for the Management of Palmoplantar Pustulosis

conference reporter
By Joel M. Gelfand, MD, MSCE

Oncology

Prostate-Specific Membrane Antigen Positron Emission Tomography Guidance for Salvage Therapy

conference reporter
By William K. Oh, MD

Allergy & Immunology

Treatment Selection Strategies for Food Allergies

conference reporter
By Sayantani Sindher, MD

Oncology

Optimizing Dose and Duration of Systemic Therapies for Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Diane Reidy-Lagunes, MD

Nephrology

The Potential Role of SGLT2 Inhibitors in the Treatment of IgA Nephropathy

conference reporter
By Sayna Norouzi, MD, FASN

Oncology

Prostate Cancer Theranostics: Looking Into the Future

conference reporter
By Neha Vapiwala, MD, FACR, FASTRO, FASCO

Rheumatology

Systemic Lupus Erythematosus Burden of Disease

conference reporter
By Anca D. Askanase, MD, MPH

Allergy & Immunology

Chronic Spontaneous Urticaria: The Potential Role of Biomarkers in Predicting Treatment Response

conference reporter
By Jonathan A. Bernstein, MD

Allergy & Immunology

Emerging Treatment Options for Food Allergy Management

conference reporter
By Brian P. Vickery, MD

Oncology

Targeting the Androgen Axis in Prostate Cancer

conference reporter
By Matthew R. Smith, MD, PhD

Nephrology

Reducing Proteinuria in Patients With IgA Nephropathy

conference reporter
By Samir V. Parikh, MD, FASN

Oncology

Metastasis-Directed Therapy for Oligometastatic Prostate Cancer

conference reporter
By William K. Oh, MD

Dermatology

Updates on the Management of Plaque Psoriasis With Topical Agents

conference reporter
By Steven R. Feldman, MD, PhD

Oncology

Prostate Cancer Survivorship: Metabolic Health in Focus

conference reporter
By Peter R. Carroll, MD, MPH

Dermatology

A Treatment Approach to Plaque Psoriasis

conference reporter
By Steven R. Feldman, MD, PhD

Allergy & Immunology

Food Allergies: Recent Data and Future Directions With Oral Immunotherapy

conference reporter
By Brian P. Vickery, MD

Allergy & Immunology

The Role of Biologic Therapy in the Management of Chronic Spontaneous Urticaria

conference reporter
By Allen P. Kaplan, MD

Hematology

Conference Reporter in PNH to Cover Key Topics Being Presented at ASH 2024

conference reporter
By Vahid Afshar-Kharghan, MD; Ronald S. Go, MD

Oncology

Progress With Prostate-Specific Membrane Antigen: Current and Ongoing Trials

conference reporter
By Peter R. Carroll, MD, MPH

Nephrology

IgA Nephropathy: The Role of Complement and Its Targeted Therapies

conference reporter
By Samir V. Parikh, MD, FASN

Oncology

The Role of Radiation Oncologists in Radiopharmaceutical Therapy

conference reporter
By Oliver Sartor, MD

Dermatology

Newer Biologic Agents for the Treatment of Plaque Psoriasis

conference reporter
By Steven R. Feldman, MD, PhD

Rheumatology

Chimeric Antigen Receptor T-Cell Therapy for Systemic Lupus Erythematosus

conference reporter
By George C. Tsokos, MD

Allergy & Immunology

Conference Reporter in Food Allergies to Cover Key Topics Being Presented at the ACAAI 2024

conference reporter
By Brian P. Vickery, MD; Sayantani Sindher, MD

Allergy & Immunology

Management of Refractory Chronic Spontaneous Urticaria

conference reporter
By Allen P. Kaplan, MD

Oncology

Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2024 NANETS Multidisciplinary NET Medical Symposium

conference reporter
By Jennifer R. Eads, MD; Diane Reidy-Lagunes, MD

Oncology

Emerging Treatment Options for Advanced Prostate Cancer

conference reporter
By Andrew J. Armstrong, MD, MSc

Dermatology

Conference Reporter in Plaque Psoriasis to Cover Key Topics Being Presented at the Society of Dermatology Physician Associates 2024

conference reporter
By Douglas DiRuggiero, DMSc, MHS, PA-C; Steven R. Feldman, MD, PhD

Oncology

Conference Reporter in Prostate Cancer to Cover Key Topics Being Presented at the Annual Prostate Cancer Foundation Scientific Retreat 2024

conference reporter
By Peter R. Carroll, MD, MPH; Neha Vapiwala, MD, FACR, FASTRO, FASCO

Oncology

Quality of Life After Definitive Treatment for Prostate Cancer

conference reporter
By Oliver Sartor, MD

Rheumatology

Unmet Needs in the Treatment of Systemic Lupus Erythematosus

conference reporter
By Anca D. Askanase, MD, MPH

Oncology

Precision Medicine in Prostate Cancer

conference reporter
By Andrew J. Armstrong, MD, MSc

Oncology

Insights and Guidance on Unfavorable Intermediate-Risk Prostate Cancer

conference reporter
By Oliver Sartor, MD

Dermatology

Conference Reporter in Plaque Psoriasis to Cover Key Topics Being Presented at the Fall Clinical Dermatology Conference 2024

conference reporter
By Steven R. Feldman, MD, PhD; Joel M. Gelfand, MD, MSCE

Rheumatology

Systemic Lupus Erythematosus: From Pathophysiology to Treatment

conference reporter
By Anca D. Askanase, MD, MPH

Rheumatology

Conference Reporter in SLE to Cover Key Topics Being Presented at ACR 2024

conference reporter
By Anca D. Askanase, MD, MPH; George C. Tsokos, MD

Nephrology

Conference Reporter in IgAN to Cover Key Topics Being Presented at ASN 2024

conference reporter
By Samir V. Parikh, MD, FASN; Sayna Norouzi, MD, FASN

Allergy & Immunology

Conference Reporter in CSU to Cover Key Topics Being Presented at the Fall Clinical Dermatology Conference 2024

conference reporter
By Jonathan A. Bernstein, MD; Allen P. Kaplan, MD

Oncology

Hitting the Mark With Targeted Therapies for Prostate Cancer

conference reporter
By Andrew J. Armstrong, MD, MSc

Oncology

Conference Reporter in Prostate Cancer to Cover Key Topics Being Presented at ASTRO 2024

conference reporter
By William K. Oh, MD; Oliver Sartor, MD

Oncology

The Earlier Identification of Potentially Lethal Prostate Cancer

conference reporter
By Daniel P. Petrylak, MD

Oncology

Conference Reporter in Prostate Cancer to Cover Key Topics Being Presented at the ESMO Congress 2024

conference reporter
By Andrew J. Armstrong, MD, MSc; Matthew R. Smith, MD, PhD

Oncology

The Role of Predictive Biomarkers for Patients With HR+/HER2- Breast Cancer

conference reporter
By Sara M. Tolaney, MD, MPH

Oncology

Perspectives on Neoadjuvant and Adjuvant Immunotherapies for Melanoma

conference reporter
By John M. Kirkwood, MD

Oncology

First-line CDK4/6 Inhibitor Considerations in HR+/HER2- Advanced Breast Cancer

conference reporter
By Sara M. Tolaney, MD, MPH

Oncology

Advancing Toward a Cure for Melanoma

conference reporter
By John M. Kirkwood, MD

Oncology

The Future of Individualized Therapy for Melanoma

conference reporter
By John M. Kirkwood, MD

Nephrology

Drug Pipeline for IgA Nephropathy: Available and Future Therapies

conference reporter
By Samir V. Parikh, MD, FASN

Oncology

Advancing the Understanding of HR+/HER2- Breast Cancer Treatment

conference reporter
By Sara M. Tolaney, MD, MPH

Oncology

Advanced Prostate Cancer: Improving Upon the Standard of Care

conference reporter
By Daniel P. Petrylak, MD

Nephrology

An Update on Glomerular Disease

conference reporter
By Samir V. Parikh, MD, FASN

Oncology

Personalizing Prostate Cancer Treatment: The Patient and the Tumor

conference reporter
By Oliver Sartor, MD

Oncology

HR+/HER2- Breast Cancer and the Problem of Resistance to Endocrine Therapies

conference reporter
By William J. Gradishar, MD, FACP

Oncology

Sequencing Therapies in Patients With BRAF-Mutated Melanoma

conference reporter
By Elizabeth I. Buchbinder, MD

Oncology

Optimizing Targeted Therapy for Patients With Prostate Cancer

conference reporter
By Oliver Sartor, MD

Oncology

The Importance of Next-Generation Sequencing in Guiding Therapy Selection

conference reporter
By William J. Gradishar, MD, FACP

Nephrology

Complement Cascade Dysregulation in Primary Glomerulopathies

conference reporter
By Samir V. Parikh, MD, FASN

Rheumatology

A Role for Interferon in the Treatment of Systemic Lupus Erythematosus

conference reporter
By Anca D. Askanase, MD, MPH

Oncology

Treating Immunotherapy-Refractory or -Resistant Melanoma

conference reporter
By Elizabeth I. Buchbinder, MD

Oncology

Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer

conference reporter
By Oliver Sartor, MD

Nephrology

IgA Nephropathy in Children and the Transition to Adult Care

conference reporter
By Jai Radhakrishnan, MD, MS

Oncology

Second- and Later-line Treatments for Advanced/Metastatic HR+/HER2- Breast Cancer

conference reporter
By William J. Gradishar, MD, FACP

Rheumatology

Personalized and Precision Treatment for Systemic Lupus Erythematosus

conference reporter
By George C. Tsokos, MD

Oncology

Tumor-Infiltrating Lymphocyte Therapies: Current Strategies and Future Directions

conference reporter
By Elizabeth I. Buchbinder, MD

Nephrology

Kidney Transplant Outcomes in Patients With IgA Nephropathy

conference reporter
By Jai Radhakrishnan, MD, MS

Nephrology

Glomerular Diseases: Encouraging Patients to Consider Clinical Trials

conference reporter
By Jai Radhakrishnan, MD, MS

Oncology

Conference Reporter in Prostate Cancer to Cover Key Topics Being Presented at the 2024 SNMMI Annual Meeting

conference reporter
By Daniel P. Petrylak, MD; Oliver Sartor, MD

Rheumatology

Impressions on Current and Emerging Treatments for Systemic Lupus Erythematosus

conference reporter
By George C. Tsokos, MD

Oncology

Conference Reporter in Melanoma to Cover Key Topics Being Presented at the 2024 ASCO Annual Meeting

conference reporter
By Elizabeth I. Buchbinder, MD; John M. Kirkwood, MD

Dermatology

Challenging Cases in Psoriasis

conference reporter
By Bruce E. Strober, MD, PhD, FAAD

Oncology

Conference Reporter in HR+ HER2- Breast Cancer to Cover Key Topics Being Presented at the 2024 ASCO Annual Meeting

conference reporter
By William J. Gradishar, MD, FACP; Sara M. Tolaney, MD, MPH

Nephrology

Conference Reporter in IgAN & C3G to Cover Key Topics Being Presented at the NKF SCM24

conference reporter
By Samir V. Parikh, MD, FASN; Jai Radhakrishnan, MD, MS

Rheumatology

Conference Reporter in Systemic Lupus Erythematosus to Cover Key Topics Being Presented at CCR East and CCR West 2024

conference reporter
By Anca D. Askanase, MD, MPH; George C. Tsokos, MD

Allergy & Immunology

Immunotherapy for Food Allergies: New Methods and Delivery Options

conference reporter
By Ruchi Gupta, MD, MPH

Allergy & Immunology

Food and Environmental Allergy Interactions: Understanding Pollen Food Allergy Syndrome

conference reporter
By Ruchi Gupta, MD, MPH

Allergy & Immunology

The Primary Prevention of Food Allergies and the Role of Early Exposure

conference reporter
By Ruchi Gupta, MD, MPH

Dermatology

Challenges in the Management of Genital Psoriasis

conference reporter
By Bruce E. Strober, MD, PhD, FAAD

Allergy & Immunology

The Role of Biologic Therapy in IgE-Mediated Food Allergies

conference reporter
By Edwin Kim, MD, MS

Oncology

Surveillance After Complete Resection of Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Timothy J. Hobday, MD

Allergy & Immunology

The Importance of Shared Decision Making in the Management of Food Allergies

conference reporter
By Edwin Kim, MD, MS

Oncology

Gastroenteropancreatic Neuroendocrine Tumors: Clinical Trials in Progress

conference reporter
By Timothy J. Hobday, MD

Dermatology

The Rapidly Changing Treatment Landscape of Psoriasis and Psoriatic Arthritis

conference reporter
By Steven R. Feldman, MD, PhD

Dermatology

Plaque Psoriasis in the Real-World Pediatric Population

conference reporter
By Bruce E. Strober, MD, PhD, FAAD

Oncology

Potential Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Timothy J. Hobday, MD

Allergy & Immunology

Diagnostic Advancements in Food Allergies: Expanding Beyond the Use of the Oral Food Challenge

conference reporter
By Edwin Kim, MD, MS

Dermatology

Health-Related Quality of Life in Patients With Plaque Psoriasis

conference reporter
By Steven R. Feldman, MD, PhD

Oncology

Treating Midgut vs Non-Midgut Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Jonathan R. Strosberg, MD

Dermatology

Screening Patients With Plaque Psoriasis for Biologic Treatment

conference reporter
By Steven R. Feldman, MD, PhD

Oncology

Gastric Neuroendocrine Tumors: Updates and Perspectives

conference reporter
By Jonathan R. Strosberg, MD

Allergy & Immunology

Conference Reporter in Food Allergies to Cover Key Topics Being Presented at the AAAAI 2024

conference reporter
By Ruchi Gupta, MD, MPH; Edwin Kim, MD, MS

Oncology

Peptide Receptor Radionuclide Therapy for Neuroendocrine Neoplasms

conference reporter
By Jonathan R. Strosberg, MD

Hematology

Hematologic Outcomes in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Ronald S. Go, MD

Hematology

Infection Risk and Vaccination Response in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Ronald S. Go, MD

Hematology

Updates on Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Ronald S. Go, MD

Hematology

Revisiting the Distinct Phenotypic Categories of Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP

Hematology

Novel Complement-Blocking Strategies in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP

Oncology

Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2024 ASCO-GI Cancers Symposium

conference reporter
By Timothy J. Hobday, MD; Jonathan R. Strosberg, MD

Hematology

Clonal Trajectories and Clonal Evolution in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP

Nephrology

Living With Fatigue From Glomerular Disease

conference reporter
By Carla M. Nester, MD, MSA, FASN

Rheumatology

Conference Highlights: Toward Disease Modification in Systemic Lupus Erythematosus

conference reporter
By Anca D. Askanase, MD, MPH

Dermatology

Conference Reporter in Plaque Psoriasis to Cover Key Topics Being Presented at the Maui Derm Hawaii 2024 Meeting

conference reporter
By Steven R. Feldman, MD, PhD; Bruce E. Strober, MD, PhD, FAAD

Dermatology

The Emerging Role of JAK Inhibitors in the Management of Psoriasis

conference reporter
By Bruce E. Strober, MD, PhD, FAAD

Nephrology

Role of Cytokines in Immunoglobulin A Nephropathy: Pathogenesis and Novel Therapies

conference reporter
By Carla M. Nester, MD, MSA, FASN

Rheumatology

Real-World Data on Systemic Lupus Erythematosus

conference reporter
By Maureen A. McMahon, MD

Dermatology

Clinical Insights Into the Topical Treatment of Psoriasis

conference reporter
By Bruce E. Strober, MD, PhD, FAAD

Nephrology

Controversies in Complement 3 Glomerulopathy

conference reporter
By Carla M. Nester, MD, MSA, FASN

Rheumatology

Update on Systemic Lupus Erythematosus Biomarkers and Prognostication

conference reporter
By Vasileios C. Kyttaris, MD

Dermatology

Real-World Experience With IL-17 and IL-23 Inhibitors for Plaque Psoriasis

conference reporter
By Boni E. Elewski, MD

Oncology

Personalizing Therapy for Patients With Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Thorvadur R. Halfdanarson, MD

Nephrology

Challenges in Managing Complement 3 Glomerulopathy

conference reporter
By Andrew S. Bomback, MD, MPH

Hematology

Conference Reporter in Paroxysmal Nocturnal Hemoglobinuria to Cover Key Topics Being Presented at the 65th ASH Annual Meeting and Exposition

conference reporter
By Ronald S. Go, MD; Jaroslaw P. Maciejewski, MD, PhD, FACP

Oncology

Gastroenteropancreatic Neuroendocrine Tumors: Clinical Trials and Future Directions

conference reporter
By Thorvadur R. Halfdanarson, MD

Nephrology

The Evolving Treatment Landscape for Immunoglobulin A Nephropathy

conference reporter
By Andrew S. Bomback, MD, MPH

Dermatology

Psoriasis in Patients With Skin of Color: Diagnosis and Management Considerations

conference reporter
By Boni E. Elewski, MD

Oncology

Interdisciplinary Perspectives on Grade Evolution in Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Jennifer R. Eads, MD

Nephrology

Exploring the Therapeutic Landscape for Complement-Mediated Kidney Diseases

conference reporter
By Andrew S. Bomback, MD, MPH

Dermatology

Choosing Systemic Agents for Psoriasis: What Clinicians Need to Know Now

conference reporter
By Boni E. Elewski, MD

Rheumatology

Autoimmunity and Autoantibody Profiles in Systemic Lupus Erythematosus

conference reporter
By Vasileios C. Kyttaris, MD

Rheumatology

Advancements in Systemic Lupus Erythematosus: Entering a New Era

conference reporter
By Maureen A. McMahon, MD

Oncology

Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2023 NANETS Multidisciplinary NET Medical Symposium

conference reporter
By Jennifer R. Eads, MD; Thorvadur R. Halfdanarson, MD

Dermatology

Conference Reporter in Plaque Psoriasis to Cover Key Topics Being Presented at the 2023 Fall Clinical Dermatology Conference

conference reporter
By Boni E. Elewski, MD; Bruce E. Strober, MD, PhD, FAAD

Oncology

Transitioning From a Conventional Imaging Paradigm to a Next-Generation Imaging Paradigm

conference reporter
By Tom Iarocci, MD

Oncology

Conference Reporter and Highlight Article: Important Aspects of Care in Advanced Prostate Cancer

conference commentary
By Tanya B. Dorff, MD; Tom Iarocci, MD

Oncology

Conference Reporter and Highlight Article: Spotlight on Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy

conference commentary
By Scott T. Tagawa, MD, MS, FACP; Tom Iarocci, MD

Oncology

Patient Selection and Treatment Personalization With Prostate-Specific Membrane Antigen–Directed Radioligand Therapy

conference reporter
By Tom Iarocci, MD

Oncology

Thinking Differently About Breast Cancer in Young Women

conference reporter
By Ian Krop, MD, PhD

Oncology

CDK4/6 Inhibition and Endocrine Resistance in Advanced HR+ HER2- Breast Cancer

conference reporter
By Ian Krop, MD, PhD

Oncology

Updates on Prostate-Specific Membrane Antigen Positron Emission Tomography

conference reporter
By Tom Iarocci, MD

Oncology

Selective Estrogen Receptor Degraders and Other Novel Agents in Breast Cancer: Where Do We Stand?

conference reporter
By Sara M. Tolaney, MD, MPH

Oncology

Chronic Myeloid Leukemia at EHA2023: Conference Roundup

conference reporter
By Daniel J. DeAngelo, MD, PhD

Oncology

CDK4/6 Inhibition in Advanced HR+ HER2- Breast Cancer

conference reporter
By Sara M. Tolaney, MD, MPH

Oncology

Treatment-Free Remission in Chronic Myeloid Leukemia: How to Optimize Eligibility and Improve Success Rates

conference reporter
By Elias Jabbour, MD

Oncology

Gaining Experience With Prostate-Specific Membrane Antigen–Directed Radioligand Therapy

conference reporter
By Tom Iarocci, MD

Oncology

Conference Reporter in Metastatic Prostate Cancer to Cover Key Topics Being Presented at SNMMI 2023

conference reporter
By Tom Iarocci, MD

Oncology

Late-line Treatment in Chronic-Phase Chronic Myeloid Leukemia

conference reporter
By Elias Jabbour, MD

Rheumatology

Systemic Lupus Erythematosus Roundup at Eastern Rheumatology Congress

conference reporter
By Maureen A. McMahon, MD

Rheumatology

Addressing Refractory Systemic Lupus Erythematosus

conference reporter
By Anca D. Askanase, MD, MPH

Nephrology

Glomerular Disease: Conference Roundup on Immunoglobulin A Nephropathy, Complement 3 Glomerulopathy, and Focal Segmental Glomerulosclerosis

conference reporter
By Samir V. Parikh, MD, FASN

Oncology

Conference Reporter in HR+ HER2- Breast Cancer to Cover Key Topics Being Presented at the 2023 ASCO Annual Meeting

conference reporter
By Ian Krop, MD, PhD; Sara M. Tolaney, MD, MPH

Nephrology

New Studies and Emerging Data on Complement-Driven Kidney Diseases

conference reporter
By Samir V. Parikh, MD, FASN

Rheumatology

Systemic Lupus Erythematosus: Response to Treatment With Newer Therapies

conference reporter
By Vasileios C. Kyttaris, MD

Nephrology

Case for Consideration: Glomerular Diseases at a National Kidney Disease Conference

conference reporter
By Carla M. Nester, MD, MSA, FASN

Oncology

Conference Reporter in Chronic Myeloid Leukemia to Cover Key Topics Being Presented at EHA2023 Hybrid Congress

conference reporter
By Daniel J. DeAngelo, MD, PhD; Elias Jabbour, MD

Nephrology

Unmet Needs and Targeted Treatments for Glomerular Diseases

conference reporter
By Carla M. Nester, MD, MSA, FASN

Nephrology

Improving Outcomes in Complement-Mediated Kidney Disease

conference reporter
By Andrew S. Bomback, MD, MPH

Nephrology

Immunoglobulin A Nephropathy: Challenges and Emerging Treatments

conference reporter
By Andrew S. Bomback, MD, MPH

Rheumatology

Conference Reporter in Systemic Lupus Erythematosus to Cover Key Topics Being Presented at CCR East, CCR West, and ACR Convergence 2023

conference reporter
By Anca D. Askanase, MD, MPH; Maureen A. McMahon, MD; Vasileios C. Kyttaris, MD

Nephrology

Conference Reporter in IgAN and C3G – Complement Mediated Kidney Diseases to Cover Key Topics Being Presented at the NKF 2023 Spring Clinical Meetings

conference reporter
By Andrew S. Bomback, MD, MPH; Carla M. Nester, MD, MSA, FASN; Samir V. Parikh, MD, FASN

Oncology

Treatment-Free Remission in Chronic Myeloid Leukemia

conference reporter
By Michael J. Mauro, MD

Oncology

Chronic Myeloid Leukemia: Unmet Needs and Trials in Progress

conference reporter
By Michael J. Mauro, MD

Hematology

Next-Generation Complement Inhibitors for Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP

Hematology

Flow Cytometry and Clonal Considerations in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP

Oncology

Later-line Treatments in Chronic Myeloid Leukemia

conference reporter
By Neil P. Shah, MD, PhD

Hematology

Future Directions for Paroxysmal Nocturnal Hemoglobinuria Treatment

conference reporter
By Carlos M. de Castro III, MD

Hematology

Extravascular Hemolysis and Residual Anemia in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Carlos M. de Castro III, MD

Oncology

Tolerability of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

conference reporter
By Neil P. Shah, MD, PhD

Oncology

Evolving Practices in the Treatment of Chronic Myeloid Leukemia

conference reporter
By Hagop M. Kantarjian, MD

Hematology

Complications and Comorbidities in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Ronald S. Go, MD

Hematology

Paroxysmal Nocturnal Hemoglobinuria: Initial Presentation, Diagnosis, and Management

conference reporter
By Ronald S. Go, MD

Oncology

BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Current Landscape

conference reporter
By Hagop M. Kantarjian, MD

Hematology

Conference Reporter in Paroxysmal Nocturnal Hemoglobinuria to Cover Key Topics Being Presented at the 64th ASH Annual Meeting and Exposition

conference reporter
By Carlos M. de Castro III, MD; Jaroslaw P. Maciejewski, MD, PhD, FACP; Ronald S. Go, MD

Ophthalmology

Novel Disease Biomarkers and Artificial Intelligence in Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By SriniVas R. Sadda, MD, FARVO

Ophthalmology

Optical Coherence Tomography and Multimodal Diagnostics in Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By SriniVas R. Sadda, MD, FARVO

Ophthalmology

Geographic Atrophy in Age-Related Macular Degeneration: Novel Strategies Targeting the Complement System

conference reporter
By Carl D. Regillo, MD, FACS, FASRS

Ophthalmology

The Natural History of Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By Carl D. Regillo, MD, FACS, FASRS

Ophthalmology

Potential of Gene Therapy for Age-Related Macular Degeneration

conference reporter
By Peter K. Kaiser, MD

Ophthalmology

Future Management of Geographic Atrophy in Age-Related Macular Degeneration

conference reporter
By Peter K. Kaiser, MD

Ophthalmology

Conference Reporter in Geographic Atrophy to Cover Key Topics Being Presented at the 2022 Annual Meeting of the American Academy of Ophthalmology

conference reporter
By Carl D. Regillo, MD, FACS, FASRS; Peter K. Kaiser, MD; SriniVas R. Sadda, MD, FARVO

Oncology

Earlier-Stage Non–Small Cell Lung Cancer: Immunotherapy Highlights

conference reporter
By Bruce E. Johnson, MD

Oncology

Advanced Solid Tumors: New Directions for Checkpoint Blockade

conference reporter
By Bruce E. Johnson, MD

Oncology

Biomarkers of Response to PD-1/PD-L1–Directed Therapy

conference reporter
By Mark G. Kris, MD

Oncology

Appreciating the Complexity: Immune Escape and Immune-Related Side Effects

conference reporter
By Mark G. Kris, MD

Oncology

Precision Immunotherapy and Novel Concepts in Immuno-Oncology

conference reporter
By Julie R. Brahmer, MD, MSc

Oncology

Established and Emerging Immune Checkpoint Inhibitor Combination Strategies

conference reporter
By Julie R. Brahmer, MD, MSc

Oncology

Conference Reporter in Immuno-Oncology to Cover Key Topics Being Presented at the 2022 ASCO Annual Meeting

conference reporter
By Bruce E. Johnson, MD; Julie R. Brahmer, MD, MSc; Mark G. Kris, MD

Oncology

First-in-Class Prospects and New Targets in Advanced Prostate Cancer

conference reporter
By Christopher J. Logothetis, MD

Oncology

Treatment Decision Making: Understanding What Matters to Patients With Metastatic Castration-Resistant Prostate Cancer

conference reporter
By Christopher J. Logothetis, MD

Oncology

Predictive and Prognostic Value of Advanced Positron Emission Tomography Imaging

conference reporter
By Scott T. Tagawa, MD, MS, FACP

Oncology

Implementing Novel Targeted Radioligand Therapies

conference reporter
By Scott T. Tagawa, MD, MS, FACP

Oncology

Disparities in Prostate Cancer Care

conference reporter
By Judd W. Moul, MD

Oncology

Biomarker Testing in the Emerging Treatment Era

conference reporter
By Judd W. Moul, MD

Oncology

Chronic Lymphocytic Leukemia: Real-World Data on Testing and Treatment

conference reporter
By Anthony R. Mato, MD, MSCE

Oncology

Investigational Novel-Novel Combinations for Chronic Lymphocytic Leukemia

conference reporter
By Anthony R. Mato, MD, MSCE

Oncology

COVID-19 in Chronic Myeloid Leukemia and Other Hematologic Malignancies

conference reporter
By Jorge E. Cortes, MD

Oncology

Molecular Status for the Discontinuation of Tyrosine Kinase Inhibitor Therapy

conference reporter
By Jorge E. Cortes, MD

Oncology

Resistance and Persistence in Chronic Myeloid Leukemia

conference reporter
By Elias Jabbour, MD

Oncology

Unmet Needs in Chronic Myeloid Leukemia and Insights From Next-Generation Studies

conference reporter
By Elias Jabbour, MD

Oncology

Taking a Whole-Patient Approach to Treating Chronic Lymphocytic Leukemia

conference reporter
By Matthew S. Davids, MD, MMSc

Oncology

Extending Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia

conference reporter
By Matthew S. Davids, MD, MMSc

Oncology

Chronic Lymphocytic Leukemia Treatment Patterns in the Era of Novel Agents

conference reporter
By Jan A. Burger, MD, PhD

Oncology

Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Real-World Data

conference reporter
By Daniel J. DeAngelo, MD, PhD

Oncology

Important Frontiers in Chronic Myeloid Leukemia Research

conference reporter
By Daniel J. DeAngelo, MD, PhD

Oncology

Long-term Survival Data With Preferred Frontline Therapies for Chronic Lymphocytic Leukemia

conference reporter
By Jan A. Burger, MD, PhD

Hepatology

Noninvasive Testing for Fatty Liver Disease and Its Different Phenotypes

conference reporter
By Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD

Hepatology

Multidisciplinary Care for Nonalcoholic Fatty Liver Disease

conference reporter
By Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD

Hepatology

The Gut-Liver Axis and the Microbiome in Liver Inflammation and Fibrosis

conference reporter
By Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD

Hepatology

Novel Approaches to Detect Liver Disease

conference reporter
By Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD

Hepatology

Therapies on the Horizon for Nonalcoholic Steatohepatitis

conference reporter
By Rohit Loomba, MD, MHSc

Oncology

Conference Reporter in Chronic Lymphocytic Leukemia to Cover Key Topics Being Presented at the 63rd ASH Annual Meeting and Exposition

conference reporter
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Matthew S. Davids, MD, MMSc

Hepatology

Noninvasive Tests to Risk Stratify Patients With Fatty Liver Disease

conference reporter
By Rohit Loomba, MD, MHSc

Hepatology

Conference Reporter in Liver Fibrosis to Cover Key Topics Being Presented at Recent Liver Disease Meeting

conference reporter
By Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD; Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD; Rohit Loomba, MD, MHSc

Oncology

Imaging-Based Patient Selection for Advanced Prostate Cancer Therapies

conference reporter
By Michael S. Cookson, MD, MMHC, FACS

Oncology

Practice-Changing Radiology and Nuclear Medicine in Advanced Prostate Cancer

conference reporter
By Michael S. Cookson, MD, MMHC, FACS

Oncology

Advanced Prostate Cancer: Novel Approaches for Distant Disease

conference reporter
By Robert Dreicer, MD, MS, MACP, FASCO

Oncology

Biomarker-Driven Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer

conference reporter
By Robert Dreicer, MD, MS, MACP, FASCO

Oncology

High-Risk Locally Advanced Prostate Cancer: Session Roundup

conference reporter
By Daniel P. Petrylak, MD

Oncology

Metastatic Hormone-Sensitive Prostate Cancer: Analyses and Emerging Data

conference reporter
By Daniel P. Petrylak, MD

Oncology

Genomic Testing and Predictive Biomarkers in Advanced Prostate Cancer

conference reporter
By William K. Oh, MD

Oncology

Clinical Trial Announcements and Studies to Follow

conference reporter
By William K. Oh, MD

Oncology

Gonadotropin-Releasing Hormone Agonists and Antagonists: Updates and Considerations

conference reporter
By Peter R. Carroll, MD, MPH

Oncology

Controversies in Urology: Prostate Biopsy Best Practices

conference reporter
By Peter R. Carroll, MD, MPH

Oncology

The Future of Urologic Oncology: Treatment Advances Spur Discussion

conference reporter
By Joseph A. Smith Jr, MD

Oncology

Guidelines From the Advanced Prostate Cancer Panel

conference reporter
By Joseph A. Smith Jr, MD

Oncology

Conference Reporter in Advanced Hormone-Sensitive Prostate Cancer to Cover Key Topics Being Presented at AUA2021

conference reporter
By Daniel P. Petrylak, MD; Joseph A. Smith Jr, MD; Peter R. Carroll, MD, MPH

Oncology

Promise in Treatment Personalization for Advanced Prostate Cancer

conference reporter
By E. David Crawford, MD

Oncology

Metastatic Prostate Cancer: Predictive Biomarkers for Tailored Therapy

conference reporter
By E. David Crawford, MD

Oncology

Novel and Emerging Treatments for Progressive Metastatic Castration-Resistant Prostate Cancer

conference reporter
By William K. Oh, MD

Oncology

Treatment Sequence in Patients With Castration-Resistant Prostate Cancer

conference reporter
By William K. Oh, MD

Oncology

High-Risk and Locally Advanced Prostate Cancer: Clinical Roundup

conference reporter
By Peter R. Carroll, MD, MPH

Oncology

Prostate-Specific Membrane Antigen–Targeted Therapies: Expert Insights

conference reporter
By Peter R. Carroll, MD, MPH

Neurology

Real-World Care of Patients With Epilepsy

conference reporter
By Sara Hocker, MD, FAAN

Neurology

Drug-Resistant Epilepsy and Related Clinical Trials and Registries

conference reporter
By Sara Hocker, MD, FAAN

Oncology

Aggressive B-Cell Non-Hodgkin Lymphoma: Molecular Profiling and Post-Treatment Surveillance

conference reporter
By David Miklos, MD, PhD

Oncology

Expanding Horizons: Antibody-Based Therapy in Multiple Myeloma

conference reporter
By Paul G. Richardson, MD

Oncology

Novel and Emerging Therapeutic Strategies for Multiple Myeloma

conference reporter
By Paul G. Richardson, MD

Neurology

Newer and Emerging Therapies for Uncontrolled Focal Seizures

conference reporter
By John M. Stern, MD

Oncology

Optimizing CAR T-Cell Therapy and Durability of Response in Aggressive B-Cell Lymphoma

conference reporter
By Frederick L. Locke, MD

Neurology

Epileptic Syndromes and the Future of Epilepsy Genetics

conference reporter
By John M. Stern, MD

Oncology

Cellular and Immune-Based Therapies for Relapsed Aggressive B-Cell Lymphoma

conference reporter
By Frederick L. Locke, MD

Oncology

Research to Address Unmet Needs in Multiple Myeloma

conference reporter
By S. Vincent Rajkumar, MD

Neurology

Psychiatric Comorbidity and the Evaluation of Epilepsy

conference reporter
By Gregory L. Krauss, MD

Oncology

Frail and/or Older Patients With Multiple Myeloma: ASH 2020 Roundup

conference reporter
By S. Vincent Rajkumar, MD

Oncology

Unmet Treatment Needs in Aggressive B-Cell Lymphoma

conference reporter
By David Miklos, MD, PhD

Oncology

Updates on Multiple Myeloma and Immunoglobulin Light Chain Amyloidosis

conference reporter
By Robert Z. Orlowski, MD, PhD

Neurology

Achieving Seizure Freedom in Patients With Drug-Resistant Epilepsy

conference reporter
By Gregory L. Krauss, MD

Oncology

Novel and Evolving Therapeutic Constructs in Aggressive B-Cell Lymphoma

conference reporter
By Jeremy S. Abramson, MD, MMSc

Oncology

CAR T-Cell Therapies, Bispecific Antibodies, and Antibody Conjugates

conference reporter
By Robert Z. Orlowski, MD, PhD

Oncology

Treatment of Double-Hit Lymphomas and Other High-Risk Subsets

conference reporter
By Jeremy S. Abramson, MD, MMSc

Neurology

Conference Reporter in Epilepsy to Cover Key Topics Being Presented at AES2020

conference reporter
By Gregory L. Krauss, MD; John M. Stern, MD; Sara Hocker, MD, FAAN

Oncology

Conference Reporter in Aggressive B-Cell Lymphoma to Cover Key Topics Being Presented at the 62nd ASH Annual Meeting and Exposition

conference reporter
By David Miklos, MD, PhD; Frederick L. Locke, MD; Jeremy S. Abramson, MD, MMSc

Oncology

Conference Reporter in Multiple Myeloma to Cover Key Topics Being Presented at the 62nd ASH Annual Meeting and Exposition

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD

Infectious Diseases

Allaying Parental Concerns About Chemicals in Vaccines

conference reporter
By Sean O’Leary, MD, MPH

Infectious Diseases

Visual Indications of Infections and Their Mimickers

conference reporter
By Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

Infectious Diseases

The Red Book Committee: Questions and Answers

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA; Sean O’Leary, MD, MPH

Infectious Diseases

Antimicrobial Update: Current Susceptibility Data and Trends

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA

Infectious Diseases

Improving Vaccination Rates and Reducing Vaccine Hesitancy

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA; Sean O’Leary, MD, MPH; Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

Infectious Diseases

Changes in Vaccine Recommendations: Review and Updates

conference reporter
By Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

Infectious Diseases

Conference Reporter in Influenza to Cover Key Topics Being Presented at the 2020 AAP Virtual National Conference & Exhibition

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA; Sean O’Leary, MD, MPH; Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

Oncology

CD38 and Its Expanding Role as an Immunomodulator and Druggable Target

conference reporter
By Paul G. Richardson, MD

Oncology

Refractory Multiple Myeloma: Tailoring Treatment to Patient Characteristics

conference reporter
By S. Vincent Rajkumar, MD

Oncology

Novel Agents in the Approach to Patients With High-Risk Multiple Myeloma

conference reporter
By Robert Z. Orlowski, MD, PhD

Oncology

Clinical Considerations in Initial Treatment of Newly Diagnosed Patients With Multiple Myeloma

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD

Oncology

Treatment of Patients With Relapsed and/or Refractory and High-Risk Multiple Myeloma

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD

Oncology

Multiple Myeloma Session Roundup: Minimal Residual Disease Assessment and Implications

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD

Oncology

Conference Reporter in Multiple Myeloma to Cover Key Topics Being Presented at the ASCO20 Virtual Scientific Program and the Virtual Edition of the 25th EHA Annual Congress

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD

Rheumatology

Managing Pain in Rheumatology: Learning From the Opioid Epidemic

conference reporter
By Leonard H. Calabrese, DO

Rheumatology

Nonalcoholic Fatty Liver Disease in Rheumatoid Arthritis and Use of Hepatotoxic Medications

conference reporter
By Leonard H. Calabrese, DO

Rheumatology

Patient Management Principles for Difficult-to-Treat Rheumatoid Arthritis

conference reporter
By Alan L. Epstein, MD

Rheumatology

Pregnancy in Rheumatoid Arthritis: Principles for Clinical Practice

conference reporter
By Jonathan Kay, MD

Rheumatology

Cardiovascular Comorbidity in Rheumatoid Arthritis

conference reporter
By Alan L. Epstein, MD

Rheumatology

Vaccination Strategies for Patients With Rheumatoid Arthritis

conference reporter
By Jonathan Kay, MD

Rheumatology

Conference Reporter in Rheumatoid Arthritis to Cover Key Topics at 2019 ACR/ARP Annual Meeting

conference reporter
By Alan L. Epstein, MD; Jonathan Kay, MD; Leonard H. Calabrese, DO